Adastra Holdings Ltd C.XTRX

Alternate Symbol(s): XTXXF

Adastra Holdings Ltd. is a Canada-based company, which is engaged in the supply and manufacturing of ethnobotanical and cannabis products for lawful adult-use. The Company extracts and processes cannabis for sale to the recreational and medical markets in Canada using its large-scale extraction facility (the Facility) to produce a variety of products, including vape pens, wax, resin, infused pre-rolls, diamonds and shatter. It serves medical markets and engages in therapeutic applications. With cannabis concentrate products sold through retailers at more than 2,000 locations across Canada, Adastra's Phyto Extractions and Endgame Extracts brands are well established with a solid distribution presence. As a Health Canada licensed facility, it specializes in extraction, distillation and manufacturing of a range of cannabis-derived products. Its subsidiaries include Adastra Labs Holdings (2019) Ltd., Adastra Labs Inc., 1178562 B.C. Ltd., Adastra Brands Inc., and others.

CSE:XTRX - Post by User

Adastra Holdings Ltd > Q3 results

<< Previous

Bullboard Posts

Next >>

Post by lscfaon Dec 06, 2024 11:09am

27 Views

Post# 36349267

Q3 results

Qtr ending	Net Revenue	Gross profit	Margin	Op inc (loss)	Cfo
Q3 24	7,103,576	2,729,120	38.4%	345,068	254,579
Q2 24	6,870,289	3,029,881	44.1%	867,340	1,118,611
Q1 24	6,528,390	1,827,937	28.0%	(969,823)	125,460
Q4 23	5,000,152	1,070,305	21.4%	(1,437,644)	(469,880)
Q3 23	4,350,129	2,224,345	51.1%	(382,160)	(323,082)
Q2 23	7,100,565	2,600,000	36.6%	235,000	550,094
Q1 23	5,771,799	1,672,183	29.0%	(208,955)	127,649
Q4 22	4,153,016	2,554,812	61.5%	885,855	925,497
Q3 22	3,803,787	1,635,457	43.0%	(423,557)	74,933
Q2 22	3,051,554	1,094,067	35.9%	(394,325)	163,008
Q1 22	2,286,721	827,713	36.2%	(867,969)	(544,713)